Ameriflex Group Inc. Has $2.35 Million Stake in Procter & Gamble Company (The) $PG

Key Points

• Ameriflex Group Inc. increased its stake in Procter & Gamble by 24.0% during the first quarter, owning 13,799 shares valued at approximately $2.35 million.
• CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble, reducing his ownership by 11.16% and generating approximately $6.31 million from the transaction.
• Procter & Gamble reported a quarterly revenue of $20.89 billion and an earnings per share (EPS) of $1.48, surpassing analysts' expectations and showing a 1.7% increase from the previous year.

Ameriflex Group Inc. grew its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 24.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 13,799 shares of the company's stock after purchasing an additional 2,672 shares during the quarter. Procter & Gamble accounts for 1.0% of Ameriflex Group Inc.'s portfolio, making the stock its 19th largest position. Ameriflex Group Inc.'s holdings in Procter & Gamble were worth $2,352,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of PG. Northern Trust Corp grew its holdings in shares of Procter & Gamble by 0.8% in the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock worth $5,051,930,000 after acquiring an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Procter & Gamble by 3.5% in the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock worth $2,966,252,000 after buying an additional 583,629 shares during the period. Royal Bank of Canada boosted its position in shares of Procter & Gamble by 0.6% in the first quarter. Royal Bank of Canada now owns 17,273,679 shares of the company's stock worth $2,943,779,000 after buying an additional 111,162 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Procter & Gamble by 1.2% in the first quarter. Charles Schwab Investment Management Inc. now owns 17,090,898 shares of the company's stock worth $2,911,989,000 after buying an additional 208,991 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Procter & Gamble

In related news, CEO Sundar G. Raman sold 9,554 shares of the firm's stock in a transaction on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,511,060.64. Following the sale, the chief executive officer owned 41,886 shares of the company's stock, valued at approximately $6,624,689.76. This trade represents a 18.57% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Ma. Fatima Francisco sold 9,100 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,431,157.00. Following the completion of the sale, the chief executive officer directly owned 27,295 shares in the company, valued at $4,292,684.65. This represents a 25.00% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.18% of the stock is owned by company insiders.

Procter & Gamble Stock Performance

PG traded up $0.03 on Wednesday, hitting $158.02. 6,509,285 shares of the stock traded hands, compared to its average volume of 6,154,013. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $370.13 billion, a PE ratio of 24.27, a P/E/G ratio of 4.14 and a beta of 0.36. The business has a fifty day moving average price of $156.40 and a two-hundred day moving average price of $162.34.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company's quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a dividend of $1.0568 per share. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. Procter & Gamble's payout ratio is presently 64.98%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. BNP Paribas reissued an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Evercore ISI reissued an "in-line" rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an "equal weight" rating in a research report on Thursday, July 31st. Finally, UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $175.12.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.